Partnering in the New Age of R&D
There is a major shift occurring in our industries with companies large and small. None of us are looking to go it alone in a world where new product development can range from millions to BILLIONS. Again we looked to experts from the front lines for insights... Panelists: Paul August, VP and head of the early to candidate program for Sanofi, US ; Babak Nemat of founder of Strategic Intelligence and advisor to J&J, Bill Mulholland of Snell & Wilmer, Joan Koerber-Walker, AZBio (moderator)
SynCardia Systems, Inc.06/13/2013
Getting to the Destination: Dr. Marvin Slepian, SynCardia
Arizona Commerce Authority05/17/2013
AZ Innovation Challenge Video
The Arizona Innovation Challenge (AIC), powered by the Arizona Commerce Authority , awards the most money in the country for a technology commercialization challenge – $3 million ($1.5 million twice yearly) to the world’s most promising technology ventures. Awards range from $100,000 to $250,000 per company. The results? A big-time investment in the most talented entrepreneurs. Bringing to market products that are literally changing the way the world works. Driving wealth and job creation for the state of Arizona. Are you up for the Challenge?
Cancer Genomics: the future of personalized medicine
2012 Bioscience Leader of the Year, Robert Penny, MD, PhD shares the history of the Cancer Genome Atlas Project and a look forward at the future of personalized medicine.
CBR - 20 Years of Cord Blood Research
Cord blood stem cells have been used to treat more than 80 diseases, from leukemias and anemias to immune and metabolic disorders. Today, even more treatment options are being evaluated in cutting-edge, FDA-regulated clinical trials. This growing number of potential uses means more medical options for your family later.
Bio Ag: Foresight and Integrating Vision Systems
The University of Arizona Controlled Environment Agriculture Center Controlled Environment Agriculture (CEA) is the production of plants and their products, such as vegetables and flowers, inside structures such as greenhouses. By using CEA, we can produce high value crops at maximum productivity in an efficient and environmentally friendly way. The University of Arizona's Controlled Environment Agriculture Center (CEAC) supports education, research and outreach as part of the Department of Agricultural & Biosystems Engineering and the School of Plant Sciences - both programs of the College of Agriculture and Life Sciences. CEAC also offers an innovation platform for plant physiology, sensor technology and applied computer technology.
Ventana: The Birth of a Life Changing Idea
Ventana Medical Systems, Inc., a Member of the Roche Group, is a global leader in tissue diagnostic innovations for anatomic pathology. This video reveals the true story of a quest to improve the standard of care for a single patient -- a quest that began a new era in cancer diagnostics. Discover how automated staining is empowering histology labs worldwide to deliver prompt, personalized diagnostic information.
Tying it all together for start up success
Alan Nelson is heading the Predictive Health Analytics Initiative that aims to change the paradigm in healthcare from treating late stage disease to early diagnosis and preventive therapies that are cost-effective. He served as the Executive Director of the Biodesign Institute at ASU and holds professorships in Bioengineering and physics. He is the founder and CEO of three companies, the most recent being VisionGate, the innovator of the LuCED lung cancer early detection test. VisionGate was awarded the start-up of the year award at the recent Governors’ celebration of innovation. Alan has a PhD in Biophysics from Berkeley, holds 66 issued patents, and has published over 100 scholarly papers in biomedical imaging.
From Discovery to Development to Delivery: Biodesign
Raymond N. DuBois, MD, PhD , executive director of The Biodesign Institute at Arizona State University explains the history and the value of biodesign and shares a look at the bioinspired, use inspired, research being done by innovative teams at The Biodesign Institute in their three focus areas of health, energy, and security.
Partnering with the FDA
Michelle Ann Wells, RAC works in Regulatory Affairs at WL GORE and has spent her career navigating the maze known as the FDA. Her 20 year career includes working on the regulatory teams of Schein (Steris/Watson), Zila, The Tech Group, Bard (Impra), Medicis, and Regulatory Compliance Consulting Services. Outside of Arizona, Michelle has worked with Proctor & Gamble, Dey (Mylan), Inale (Nektar), and Pfizer.